{
  "url": "https://openlegislation.uk/national-health-service-charges-for-drugs-and-appliances-regulations-2015/regulation-13",
  "json_url": "https://openlegislation.uk/national-health-service-charges-for-drugs-and-appliances-regulations-2015/regulation-13.json",
  "legislation": "uksi/2015/570",
  "legislation_title": "The National Health Service (Charges for Drugs and Appliances) Regulations 2015",
  "legislation_url": "https://openlegislation.uk/national-health-service-charges-for-drugs-and-appliances-regulations-2015",
  "path": "regulation/13",
  "kind": "regulation",
  "number": "13",
  "heading": "Exemption from charges: risks to public health",
  "text": "(1) In the circumstances set out in paragraph (2), the following prescription items are exempt from any charge under these Regulations—\n(a) prescription items for the prevention or treatment of a condition or disease arising from an emergency that threatens, is causing or has caused serious damage or risk to public health in England or any part of England; and\n(b) prescription items, the supply of which is for, or is in anticipation of, a pandemic disease where the supply is in accordance with a prescription ..., a patient group direction, a serious shortage protocol or a protocol relating to that disease as provided for in regulation 247 of the Human Medicines Regulations 2012 (exemption for supply in the event or anticipation of pandemic disease).\n(2) Those circumstances are where—\n(a) the Secretary of State has made arrangements for supplying the prescription item to patients free of charge; or\n(b) the NHS body that is responsible for the arrangements under which the prescription item is supplied has made arrangements, with the approval of the Secretary of State, for supplying the prescription item to patients free of charge,\nand the patient is supplied with the prescription item under those arrangements.",
  "extent": null,
  "status": null,
  "version": "current",
  "annotations": [
    {
      "type": "F",
      "label": "F1",
      "text": "Words in reg. 13(1) substituted (1.3.2021) by The National Health Service (Charges and Pharmaceutical and Local Pharmaceutical Services) (Coronavirus) (Amendment) Regulations 2021, regs. 1(2), 6(3)(a)"
    },
    {
      "type": "F",
      "label": "F2",
      "text": "Words in reg. 13(1)(b) substituted (1.3.2021) by The National Health Service (Charges and Pharmaceutical and Local Pharmaceutical Services) (Coronavirus) (Amendment) Regulations 2021, regs. 1(2), 6(3)(b)"
    },
    {
      "type": "F",
      "label": "F3",
      "text": "Word in reg. 13(1)(b) omitted (21.12.2021) by virtue of The National Health Service (Charges, Primary Medical Services and Pharmaceutical and Local Pharmaceutical Services) (Coronavirus) (Further Amendments) Regulations 2021 (S.I. 2021/1346), regs. 1(2)(a), 12(2)"
    },
    {
      "type": "F",
      "label": "F4",
      "text": "Words in reg. 13(2) substituted (1.3.2021) by The National Health Service (Charges and Pharmaceutical and Local Pharmaceutical Services) (Coronavirus) (Amendment) Regulations 2021, regs. 1(2), 6(3)(b)"
    },
    {
      "type": "M",
      "label": "M1",
      "text": "S.I. 2012/1916. Regulation 247 has been amended by S.I. 2013/235."
    },
    {
      "type": "M",
      "label": "M2",
      "text": "“NHS body” is defined in section 275(1) of the National Health Service Act 2006 (c. 41)."
    }
  ],
  "outstanding_effects": [],
  "provenance": {
    "source": "legislation.gov.uk",
    "source_url": "https://www.legislation.gov.uk/uksi/2015/570/regulation/13",
    "retrieved_at": "2026-10-28T23:44:03.798764+00:00"
  },
  "licence": "Open Government Licence v3.0",
  "licence_url": "https://www.nationalarchives.gov.uk/doc/open-government-licence/version/3/",
  "attribution": "Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives."
}